Home
Clinical Resources Search
PQI: Bortezomib (Velcade®) in the First-Line Management for Multiple Myeloma

Bortezomib (Velcade®) in the First-Line Management for Multiple Myeloma

Download PQI pdf 0.21MB

Last Updated: April 29, 2024

By: Jasmine Patel, PharmD, BCOP

About this PQI

The purpose of this PQI is to discuss the option of using bortezomib for first-line treatment in multiple myeloma (MM).

How to Use a Positive Quality Intervention (PQI)

Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.

Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.

Frequently Searched

Supported by

Bortezomib (Velcade®) in the First-Line Management for Multiple Myeloma

About this PQI

How to Use a Positive Quality Intervention (PQI)

Find Similar Resources

PQI: HER2 Immunohistochemistry Testing in Metastatic Breast Cancer: Guiding Treatment Decisions and the Role of Sacituzumab Govitecan

PQI: Ivosidenib (Tibsovo) and Management of IDH1 Mutant Acute Myeloid Leukemia

PQI: Datopotamab deruxtecan (Datroway): Prophylaxis and Management of Adverse Events

PQI: Streamlining Enrollment in the Medicare Prescription Payment Plan (MPPP)

PQI in Action: Darolutamide (Nubeqa)

PQI in Action: Zolbetuximab (Vyloy) for Gastroesophageal Cancers

PQI in Action: Epcoritamab (Epkinly) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

PQI in Action: Nirogacestat (Ogsiveo) use in Management of Adults with Progressing Desmoid Tumors (or fibromatosis or aggressive fibromatosis)

S10 E7: Scaling Hope: The Future of Cell Therapy Access

S10 E5: Best Practices for Subcutaneous Administration of Anticancer Therapies

S10 E6: Modern Antibody-drug conjugates and New CINV Challenges

S10 E4: Preventing Blood Clots in Cancer Care

Toolkit: Simplify CLL Tracking in Oncology Practices

Toolkit: Optimize CLL Care in Epic

Treatment Support Kit: Elranatamab

Treatment Support Kit: Bi-Specific

Treatment Support Kit: Mirdametinib

Treatment Support Kit: Abemaciclib

Video: Akynzeo® (Ready-to-Use Vial): A Step-by-Step Video Guide

Video: Ibrutinib-Related Cardiac Toxicities: Management & Dose Modifications

Video: Neratinib for Extended Adjuvent Treatment of Adult Patients with Early-Stage HER2-Positive Breast Cancer (MIP)

Video: BRUKINSA® (Zanubrutinib) for Treatment of Relapsed or Refractory Marginal Zone Lymphoma

S7 Ep 8: Sickle Cell Disease Insights

Up Close with Teclistamab

Pomalidomide

Selinexor

Melphalan

Daratumumab and CyBorD

Isatuximab and VRd

Daratumumab and VRd

Bortezomib